1. Home
  2. PAYP vs ALKS Comparison

PAYP vs ALKS Comparison

Compare PAYP & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PayPay Corporation American Depository Shares

PAYP

PayPay Corporation American Depository Shares

N/A

Current Price

$15.50

Market Cap

10.6B

Sector

Real Estate

ML Signal

N/A

Logo Alkermes plc

ALKS

Alkermes plc

HOLD

Current Price

$52.78

Market Cap

8.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAYP
ALKS
Founded
2018
1987
Country
Japan
Ireland
Employees
4567
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.6B
8.7B
IPO Year
2026
2012

Fundamental Metrics

Financial Performance
Metric
PAYP
ALKS
Price
$15.50
$52.78
Analyst Decision
Buy
Buy
Analyst Count
9
14
Target Price
$25.54
$43.43
AVG Volume (30 Days)
910.8K
1.8M
Earning Date
08-12-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,475,899,000.00
Revenue This Year
N/A
$24.26
Revenue Next Year
$20.92
$4.47
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.07
$25.17
52 Week High
$24.89
$55.67

Technical Indicators

Market Signals
Indicator
PAYP
ALKS
Relative Strength Index (RSI) 51.35 59.36
Support Level $12.07 $50.49
Resistance Level $16.45 $55.67
Average True Range (ATR) 0.77 1.58
MACD 0.15 -0.50
Stochastic Oscillator 51.97 40.40

Price Performance

Historical Comparison
PAYP
ALKS

About PAYP PayPay Corporation American Depository Shares

PayPay Corp is a FinTech company in Japan that operates a digital finance platform centered on payments, offering a range of payment and financial services to users and merchants. The company has two reportable segments: i) Payment segment: It includes payment settlement services and related services through its PayPay app, and credit payment settlement services such as revolving and installment payment options and cash advances; and ii) Financial service segment: It includes internet banking services, securities intermediary services and PayPay Point investment-related services, and loan management services. The majority of revenue is derived from the Payment segment. Geographically, the company's maximum revenue is generated in Japan.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: